Single test for prostate cancer

A SINGLE blood test for men aged 60 could identify those most likely to develop and die from prostate cancer.

Prostate cancer is the most common cancer in men. Screening is used in certain countries, but remains open to debate with experts weighing up the benefits against the potential harms and costs of over-diagnosis and over-treatment of healthy men.

The findings in the British Medical Journal suggested the single test could pinpoint which men needed to be monitored closely and others who needed no further checks.